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	 What’s	the	best	test		
for	underlying	osteomyelitis		
in	patients	with	diabetic		
foot	ulcers?	
	 Magnetic resonance imaging
 (MRI) has	a	higher	sensitivity	and	
specificity	 (90%	 and	 79%)	 than	 plain	 ra-
diography	 (54%	 and	 68%)	 for	 diagnosing	
diabetic	 foot	 osteomyelitis.	MRI	 performs	
somewhat	better	than	any	of	several	com-
mon	tests—probe	to	bone	(PTB),	erythro-
cyte	 sedimentation	 rate	 (ESR)	 >70	 mm/
hr,	 C-reactive	 protein	 (CRP)	 >14	 mg/L,	
procalcitonin	 >0.3	 ng/mL,	 and	 ulcer	 size	
>2	 cm2—although	 PTB	 has	 the	 highest	
specificity	 of	 any	 test	 and	 is	 commonly	
used	 together	 with	MRI.	 No	 studies	 have	
directly	compared	MRI	with	a	combination	
of	these	tests,	which	may	assist	in	diagno-
sis	(strength	of	recommendation	[SOR]:	B,	
meta-analysis	of	cohort	trials	and	individu-
al	cohort	and	case	control	trial).	
Experts	 recommend	 obtaining	 plain	
films	when	 considering	 diabetic	 foot	 ulcers	
to	evaluate	for	bony	abnormalities,	soft	tissue	
gas,	and	foreign	body;	MRI	should	be	consid-
ered	in	most	situations	when	infection	is	sus-
pected	(SOR:	B,	evidence-based	guidelines).
evidence summary
One-fifth	of	patients	with	diabetes	who	have	
foot	ulcerations	will	develop	osteomyelitis.1,2	
Most	cases	of	diabetic	 foot	osteomyelitis	 re-
sult	from	the	spread	of	a	foot	infection	to	un-
derlying	bone.2	
MRI has highest sensitivity,  
probe to bone test is most specific
A	meta-analysis3	of	9	cohort	trials	(8	prospec-
tive,	1	retrospective)	of	612	patients	with	diabe-
tes	and	a	foot	ulcer	examined	the	accuracy	of	
diagnostic	methods	for	osteomyelitis	(tABLe3,4).
MRI	had	the	highest	sensitivity	(90%),	followed	
by	bone	 scan	 (81%).	Bone	 scan	was	 the	 least	
specific	(28%),	however.	Plain	film	radiography	
had	the	lowest	sensitivity	(54%).	A	PTB	test	was	
highly	specific	(91%)	but	had	moderate	sensi-
tivity	 (60%).	 (PTB	 involves	 inserting	 a	 sterile,	
blunt	stainless	steel	probe	into	an	ulcerated	le-
sion.	If	the	probe	comes	to	a	hard	stop,	consid-
ered	to	be	bone,	the	test	is	positive.)
A	 meta-analysis	 of	 21	 prospective	 and	
retrospective	 trials	 with	 1027	 diabetic	 pa-
tients	with	foot	ulcers	or	suspected	osteomy-
elitis	 found	that	ulcer	size	>2	cm2,	PTB,	and	
ESR	>70	mm/hr	were	helpful	 in	making	 the	
diagnosis.4	
Combining eSR with ulcer size  
increases specificity
A	 prospective	 trial	 of	 46	 diabetic	 patients	
hospitalized	with	 a	 foot	 infection	 examined	
the	accuracy	of	a	combination	of	clinical	and	
laboratory	 diagnostic	 features	 in	 patients	
with	 diabetic	 foot	 osteomyelitis	 that	 had	
been	 diagnosed	 by	MRI	 or	 histopathology.5	
(Twenty-four	patients	had	osteomyelitis,	and	
22	didn’t.)	
ESR	 >70	 mm/hr	 had	 a	 sensitivity	 of	
83%	and	 specificity	of	 77%	 (positive	 likeli-
hood	 ratio	 [LR+]=3.6;	 negative	 likelihood	
ratio	 [LR−]=0.22).	 Ulcer	 size	 >2	 cm2	 had	
a	 sensitivity	 of	 88%	 and	 specificity	 of	 77%	
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(LR+=3.8;	 LR−=0.16).	 Combined,	 an	 ESR	
>70	 mm/hr	 and	 ulcer	 size	 >2cm2	 had	 a	
slightly	 better	 specificity	 than	 either	 find-
ing	 alone,	 82%,	 but	 a	 lower	 sensitivity	 of	
79%	(LR+=4.4;	LR−=	0.26).	
Serum markers accurately distinguish  
osteomyelitis from infection
An	 individual	 prospective	 cohort	 trial	 of	
61	adult	patients	with	diabetes	and	a	foot	in-
fection,	 published	 after	 the	 meta-analysis4	
described	previously,	examined	the	accuracy	
of	 serum	markers	 (ESR,	CRP,	 procalcitonin)	
for	diagnosing	osteomyelitis.6	A	positive	PTB	
test	 and	 imaging	 study	 (plain	 film,	MRI,	 or	
nuclear	scintigraphy)	were	used	as	the	diag-
nostic	gold	standard.
Thirty-four	 patients	 had	 a	 soft	 tissue	 in-
fection	 and	 27	 had	 osteomyelitis.	 All	 markers	
were	higher	in	patients	with	osteomyelitis	than	
in	 patients	 with	 a	 soft	 tissue	 infection	 (ESR	
=76	mm/hr	vs	66	mm/hr;	P<.001;	CRP=25	mg/L	vs	
8.7	mg/L;	P<.001;	 procalcitonin=2.4	 ng/mL	 vs	
0.71	ng/mL;	P<.001).	The	sensitivity	and	speci-
ficity	 for	 each	 marker	 at	 its	 optimum	 points	
were:	 ESR	 >67	mm/hr	 (sensitivity	 84%;	 speci-
ficity	75%;	LR+=3.4;	LR−=0.21);	CRP	>14	mg/L	
(sensitivity	 85%;	 specificity	 83%;	 LR+=5;	
LR−=0.18);	and	procalcitonin	>0.3	ng/mL	(sen-
sitivity	81%;	specificity	71%;	LR+=2.8;	LR−=0.27).	
Type of evidence Number of 
patients
Diagnostic test Gold standard  
comparison
Pooled results
meta-analysis
of 9 cohort trials3 
(8 prospective,  
1 retrospective)  
Total N=612
4 trials; N=177 Plain film histopathology or 
bone culture
Sensitivity 54%
Specificity 68%
lr+=1.7
lr−=0.68
4 trials; N=135 mrI histopathology or 
bone culture
Sensitivity 90%
Specificity 79%
lr+=4.3
lr−=0.13
6 trials; N=185 Bone scan histopathology or 
bone culture
Sensitivity 81%
Specificity 28%
lr+=1.1
lr−=0.68
2 trials; N=288 PTB histopathology or 
bone culture
Sensitivity 60%
Specificity 91%
lr+=6.7
lr−=0.44
meta-analysis† 
of 21 cohort trials4
(8 prospective, 13 
retrospective)
Total N=1027
1 trial; N=35 ulcer >2 cm2 Bone biopsy lr+=7.2
lr−=0.48
3 trials; N=75 PTB Bone biopsy lr+=6.4
lr−=0.39
4 trials; N=108 ESr >70 mm/hr Bone biopsy lr+=11 
lr−=0.34
16 trials; N= 567
(data pooled 
for 7 trials;  
N=217)
Plain film Bone biopsy lr+=2.3
lr−=0.63
tABLe
Diagnosing	osteomyelitis:	How	the	tests	stack	up*
ESr, erythrocyte sedimentation rate; lr+, positive likelihood ratio; lr−, negative likelihood ratio; mrI, magnetic resonance imaging; PTB, probe to bone test.
* Numbers of trials and patients don't add up because multiple diagnostic tests were used in some trials.
† 10 trials were graded as a level II or III (included a blind comparison to the gold standard) and the rest were of low quality because they lacked blinding.
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Recommendations
The	 Infectious	 Diseases	 Society	 of	 America	
(IDSA)	recommends	performing	the	PTB	test	
on	 any	diabetic	 foot	 infection	with	 an	open	
wound	(level	of	evidence:	strong	moderate).7	
It	also	recommends	performing	plain	radiog-
raphy	on	 all	 patients	presenting	with	 a	new	
infection	to	evaluate	for	bony	abnormalities,	
soft	 tissue	 gas,	 and	 foreign	 bodies	 (level	 of	
evidence:	strong	moderate).	
The	IDSA,	the	American	College	of	Radi-
ology	diagnostic	imaging	expert	panel,	and	the	
National	 Institute	 for	Health	and	Clinical	Ex-
cellence	recommend	using	MRI	in	most	clini-
cal	scenarios	when	osteomyelitis	is	suspected	
(level	of	evidence:	strong	moderate).8,9																JFP
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N=231;	 mean	 difference	 [MD]=-0.54;	 95%	
CI,	-0.84	to	-0.24)	and	conjunctival	injection	
(4	 trials,	N=208;	MD=-0.51;	 95%	CI,	 -0.97	 to	
-0.05).	 NSAIDs	 weren’t	 superior	 to	 placebo	
in	 treating	 other	 ocular	 symptoms	 of	 eye-
lid	 swelling,	 ocular	 burning,	 photophobia,	
or	 foreign	 body	 sensation,	 and	 they	 had	 a	
higher	 rate	 of	 stinging	 on	 application	 (odds	
ratio=4.0;	95%	CI,	2.7-5.9).
Guideline recommends topical  
antihistamines or mast cell stabilizers
The	 American	 Academy	 of	 Ophthalmology’s	
2012	 evidence-based	 guideline	 recommends	
treating	 allergic	 conjunctivitis	 with	 topical	
antihistamines	(Level	A-1	evidence,	defined	as	
important	evidence	supported	by	at	least	one	
RCT	or	a	meta-analysis)	and	using	topical	mast	
cell	stabilizers	if	the	condition	is	recurrent.3			JFP
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